Back to search

Democritus University of Thrace (DUTH)

Μορφολογική και ανοσοϊστοχημική μελέτη ουροθηλιακών νεοπλασμάτων κύστεως σε σχέση με την πρόγνωση

Abstract

dc:description

The human epidermal growth factor receptors (HER) protein family consists of four different transmembrane receptors (HER1–HER4). The dimerization of HER members leads to the activation of intracellular RAS/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways, which plays an important role in cell proliferation, angiogenesis, invasion, and metastasis. The activation of PI3K/AKT/PTEN/mTOR pathway has been implicated in carcinogenesis or malignant potential of several cancers, including urothelial ones. The present study was conducted to investigate the expression of EGFR and HER2 proteins, as well as intracellular signaling molecules in sections of urothelial carcinomas by immunohistochemistry. In addition, we try to find out if there is any association between the protein expression of this pathway with the expression of cell adhesion molecules, such as e-cadherin, p-cadherin, and b-catenin, and with conventional clinicopathologic parameters. For these purposes, forty-one paraffin-embedded urothelial cancer tissue blocks, with adequate material and clinical follow-up, were collected. Immunostains for HER2, EGFR, MIB1, phospho-AKT, PTEN, phospho-mTOR, e-cadherin, p-cadherin, and b-catenin were performed on tissue microarrays sections. The overexpression of HER2 was found in 19.6% of the cases and it was associated with high grade tumors, high mitotic index and phosphorylation of AKT and mTOR. Muscle-invasive tumors presented both cytoplasmic and nuclear losses of PTEN expression. Two of the cases with HER2 overexpression (HER2 3+) were of high grade and they were characterized by pAKT and pmTOR protein overexpression and PTEN nuclear deletion. These patients presented the worst prognosis in this study. There was no association between HER/AKT/mTOR pathway activation and CAM expression. Although cadherins were often coexpressed, only p-cadherin immunoreactivity was associated with tumor grade and high proliferative index. In conclusion, it is demonstrating that the combination of pAKT and pmTOR expression along with a loss of PTEN expression, which reflects to an activated pathway, does not influence the expression of CAMs and it is associated with adverse clinicopathological characteristics. Hence, these patients could be the most appropriate candidates for targeted therapy, when conventional therapy fails, taking into account the side effects of these therapeutic options. The increased interest to personalize therapy leads to a thorough investigation of patients who will benefit the most from a particular treatment.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Koletsas, Nikolaos
  • Κολέτσας, Νικόλαος

Subjects

dc:subject × 14

Rights

dc:rights
Statement dc:rights
  • BY_NC_ND
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43408

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Koletsas, Nikolaos; Κολέτσας, Νικόλαος. Μορφολογική και ανοσοϊστοχημική μελέτη ουροθηλιακών νεοπλασμάτων κύστεως σε σχέση με την πρόγνωση. Democritus University of Thrace (DUTH), 2018. http://hdl.handle.net/10442/hedi/43408